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Purpose
The purpose was to assess factors that may influence
the use of IM modalities by ID physicians in their
practice.
Methods
I na2 0 1 0n a t i o n a ls u r v e yo f1 0 0 0p r a c t i c i n gI Dp h y s i -
cians, participants were asked to report the extent
(major, minor or not at all) to which the following con-
siderations played a role in their recommendation/refer-
ral of IM modalities: (1) Knowledge of how and when to
use them; (2) Amount of clinical research showing clear
benefit; (3) Insurance; (4) Cost; (5) Reliable referral base;
(6) Concern for professional reputation; (7) Fear of judg-
ment from colleagues; (8) Insufficient regulatory over-
sight of supplements; and (9) Potential drug interactions
with botanicals/supplements.
Results
A total of 311 (31%) ID physicians responded to the
survey. The mean age was 49 and 64% of respondents
were male. Their responses to the questions are listed
below.
Conclusion
For ID physicians, factors that were considered a major
influence on the use of IM modalities included: potential
drug interactions, clinical research, knowledge of IM
modalities, and regulatory oversight. Factors that played
a minor/no role in the use of IM modalities included
fear of judgment and concern for professional
reputation.
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Table 1
Factor Number of
respondents
Major
role (%)
Minor or Not
at all (%)
Drug Interactions 293 82 18
Research 294 80 20
Knowledge 294 72 28
Insurance 292 24 76
Cost 293 39 61
Referral base 288 39 61
Professionl reputation 293 14 86
Fear of judgement 293 4 96
Regulation oversight 294 69 31
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